Quick Takeaways
- Qatar Investment Authority filed SCHEDULE 13G for BioXcel Therapeutics, Inc. Common Stock, par value $0.001 (BTAI).
- Disclosed ownership: 5.2%.
- Date of event: 25 Nov 2024.
Qatar Investment Authority - 25 Nov 2024 SCHEDULE 13G Report for BioXcel Therapeutics, Inc. Common Stock, par value $0.001 (BTAI)
- Filing Manager
- Qatar Investment Authority
- Reporting Manager
- Qatar Investment Authority
- Symbol
- BTAI
- Shares outstanding
- 52,386,058 shares
- Disclosed Ownership
- 2,724,075 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G
- Filing time
- 18 Dec 2024, 17:20:21 UTC
- Date of event
- 25 Nov 2024
- Next filing
- 30 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Qatar Investment Authority disclosed 5.2% ownership in BioXcel Therapeutics, Inc. Common Stock, par value $0.001 (BTAI) on 25 Nov 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Dec 2024, 17:20.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Qatar Investment Authority | 5.2% | 2,724,075 | 2,724,075 | 0 | /s/ Andrew Watkins | Andrew Watkins**/Associate General Counsel, Head of Compliance |